Agency Forms Undergoing Paperwork Reduction Act Review, 32178-32179 [2019-14297]
Download as PDF
32178
Federal Register / Vol. 84, No. 129 / Friday, July 5, 2019 / Notices
the appropriateness of the initial
prescription. Additional topics were
identified as important to the
respondents as they expressed support
to include questions that cover
individual perceptions of responsibility/
autonomy, the importance of the role of
family and other social pressures when
deciding to make antibiotic decisions,
and the process of following up with the
resident post-prescription. The group of
respondents were comprised of a semiconvenience sample, with efforts to
target key administrative and practicing
roles within the healthcare setting to
obtain a diverse and inclusive
perspective.
Information will be used to provide
descriptive analysis reports of the
prescribing climate within long-term
care settings. We will use these data as
comparison to the initial survey
deployment to characterize any change
demonstrated within the current
antimicrobial stewardship environment
with an effort to identify key elements
based on staff interactions, perceived
challenges, and any identifiable gaps in
knowledge. The specific elements
within the survey will be used to
identify common needs shared across
prescribers as areas for further training
or intervention development (e.g.,
identified barriers to education or
training resources will result in a more
robust education component to be
included in future work). While this
second survey is not intended to
establish a direct causal relationship, it
does aim to capture differences in a pre/
post analysis style review without
which, the initial survey would simply
provide a snapshot of current levels of
knowledge, attitudes, practices and
perceived provider-level barriers to
appropriate antibiotic prescribing.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Doctors ..............................................
Core Elements of Antimicrobial
Stewardship in Nursing Homes.
Core Elements of Antimicrobial
Stewardship in Nursing Homes.
Nurse Practitioners ...........................
Total ...........................................
...........................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–14300 Filed 7–3–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–19–19ACB]
Agency Forms Undergoing Paperwork
Reduction Act Review
jbell on DSK3GLQ082PROD with NOTICES
Number of
respondents
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘The Drug
Overdose Surveillance and
Epidemiology (DOSE)’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on April 2,
2019 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
VerDate Sep<11>2014
17:54 Jul 03, 2019
Jkt 247001
Frm 00060
Fmt 4703
Average
burden per
response
(in hours)
Total burden
(in hours)
75
1
30/60
38
25
1
30/60
12
........................
........................
........................
50
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
PO 00000
Number of
responses per
respondent
Sfmt 4703
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Drug Overdose Surveillance and
Epidemiology (DOSE)—New—National
Center for Injury Prevention and Control
(NCIPC), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The rapid increase in opioid overdose
deaths since 2013, numerous severe
fentanyl and fentanyl analog outbreaks
occurring since 2015 across the United
States, and the declaration of the opioid
overdose epidemic as a national public
health emergency on October 26, 2017
have highlighted the urgent need to
rapidly establish and enhance timely
surveillance of suspected drug, opioid,
heroin, and stimulant overdoses. These
data are critical to inform timely local,
state, and regional response, especially
to acute and/or widespread multi-state
outbreaks.
This new data collection effort is an
essential component toward reducing
the opioid crisis, one of HHS
Department’s top priorities. DOSE data
is critical to our ability to rapidly
identify outbreaks and provide
situational awareness of changes in
emergency department (ED) visits
involving suspected drug, opioid,
heroin and stimulant overdoses at the
local, state, and regional level. This will
E:\FR\FM\05JYN1.SGM
05JYN1
32179
Federal Register / Vol. 84, No. 129 / Friday, July 5, 2019 / Notices
be accomplished by standardizing and
enhancing sharing of existing ED data
locally collected by 52 health
departments (all 50 state health
departments, the health department of
Puerto Rico, and the health department
of the District of Columbia) with CDC.
In addition, CDC leadership
communicates with HHS on an ongoing
basis and this data is part of its request
to better monitor, plan and implement
programs to prevent overdose and
reduce subsequent harms.
DOSE proposes to fund 52 health
departments (50 state health
departments, the health department of
Puerto Rico and the health department
of the District of Columbia) to rapidly
share existing ED data on counts of ED
visits involving suspected drug, opioid,
heroin, and stimulant overdoses using
two standard data forms (i.e., the Rapid
ED overdose data form and the ED
discharge overdose data form) and
standard CDC case definitions.
The system will leverage ED
syndromic data and hospital discharge
data on ED visits already routinely
collected by state and territorial health
departments. No new data will be
systematically collected from EDs, and
health departments will be reimbursed
by CDC for the burden related to sharing
ED data with CDC. Fifty-two funded
health departments (50 state health
departments, Puerto Rico, and the
District of Columbia) will rapidly share
existing ED data with CDC on a monthly
basis using the Rapid ED overdose data
form and standard CDC case definitions.
Data may come from different local ED
data systems, but is expected to cover at
least 75% of ED visits in the jurisdiction
(e.g., state).
CDC will require all participating
health departments to provide counts of
ED visits involving suspected drug,
opioid, heroin, and stimulant overdoses
by county, age group, sex, and time (i.e.,
month and year) in a standardized
manner using the Rapid ED overdose
data form, which is an Excel data
template. This form also collects data
quality indicators such as percent of ED
visits missing data on key variables (i.e.,
metadata). In order to assess and
improve rapid ED data sharing, all 52
participating health departments will
also be asked to share counts of ED
visits involving suspected drug, opioid,
heroin and stimulant overdoses by
county, age group, sex, and time (i.e.,
month and year) from more finalized
hospital discharge files, the current
surveillance standard. The data will be
shared with CDC on a quarterly or
yearly basis using a standardized Excel
data form, the ED discharge overdose
data form, and standard CDC case
definitions. The total estimated annual
burden hours are 1,542. There are no
costs to the respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(hours)
Form name
State health departments, the DC health department and PR health department.
Jurisdictions sharing case-level ED data with
CDC through the NSSP BioSense (OMB
#0920–0824).
State health departments, the DC health department and PR health department.
State health departments, the DC health department and PR health department.
Rapid ED overdose data form .......................
28
12
3
Rapid ED overdose data form .......................
24
12
30/60
ED discharge overdose data form .................
26
4
3
ED discharge overdose data form—Year ......
26
1
3
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–14297 Filed 7–3–19; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–19–19MM]
Agency Forms Undergoing Paperwork
Reduction Act Review
jbell on DSK3GLQ082PROD with NOTICES
Number of
respondents
Type of respondent
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Study on
Disparities in Distress Screening among
Lung and Ovarian Cancer to the Office
of Management and Budget (OMB) for
VerDate Sep<11>2014
17:54 Jul 03, 2019
Jkt 247001
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on March 6,
2019 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
E:\FR\FM\05JYN1.SGM
05JYN1
Agencies
[Federal Register Volume 84, Number 129 (Friday, July 5, 2019)]
[Notices]
[Pages 32178-32179]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-14297]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-19-19ACB]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``The Drug Overdose Surveillance and
Epidemiology (DOSE)'' to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
April 2, 2019 to obtain comments from the public and affected agencies.
CDC received one comment related to the previous notice. This notice
serves to allow an additional 30 days for public and affected agency
comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Drug Overdose Surveillance and Epidemiology (DOSE)--New--National
Center for Injury Prevention and Control (NCIPC), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The rapid increase in opioid overdose deaths since 2013, numerous
severe fentanyl and fentanyl analog outbreaks occurring since 2015
across the United States, and the declaration of the opioid overdose
epidemic as a national public health emergency on October 26, 2017 have
highlighted the urgent need to rapidly establish and enhance timely
surveillance of suspected drug, opioid, heroin, and stimulant
overdoses. These data are critical to inform timely local, state, and
regional response, especially to acute and/or widespread multi-state
outbreaks.
This new data collection effort is an essential component toward
reducing the opioid crisis, one of HHS Department's top priorities.
DOSE data is critical to our ability to rapidly identify outbreaks and
provide situational awareness of changes in emergency department (ED)
visits involving suspected drug, opioid, heroin and stimulant overdoses
at the local, state, and regional level. This will
[[Page 32179]]
be accomplished by standardizing and enhancing sharing of existing ED
data locally collected by 52 health departments (all 50 state health
departments, the health department of Puerto Rico, and the health
department of the District of Columbia) with CDC. In addition, CDC
leadership communicates with HHS on an ongoing basis and this data is
part of its request to better monitor, plan and implement programs to
prevent overdose and reduce subsequent harms.
DOSE proposes to fund 52 health departments (50 state health
departments, the health department of Puerto Rico and the health
department of the District of Columbia) to rapidly share existing ED
data on counts of ED visits involving suspected drug, opioid, heroin,
and stimulant overdoses using two standard data forms (i.e., the Rapid
ED overdose data form and the ED discharge overdose data form) and
standard CDC case definitions.
The system will leverage ED syndromic data and hospital discharge
data on ED visits already routinely collected by state and territorial
health departments. No new data will be systematically collected from
EDs, and health departments will be reimbursed by CDC for the burden
related to sharing ED data with CDC. Fifty-two funded health
departments (50 state health departments, Puerto Rico, and the District
of Columbia) will rapidly share existing ED data with CDC on a monthly
basis using the Rapid ED overdose data form and standard CDC case
definitions. Data may come from different local ED data systems, but is
expected to cover at least 75% of ED visits in the jurisdiction (e.g.,
state).
CDC will require all participating health departments to provide
counts of ED visits involving suspected drug, opioid, heroin, and
stimulant overdoses by county, age group, sex, and time (i.e., month
and year) in a standardized manner using the Rapid ED overdose data
form, which is an Excel data template. This form also collects data
quality indicators such as percent of ED visits missing data on key
variables (i.e., metadata). In order to assess and improve rapid ED
data sharing, all 52 participating health departments will also be
asked to share counts of ED visits involving suspected drug, opioid,
heroin and stimulant overdoses by county, age group, sex, and time
(i.e., month and year) from more finalized hospital discharge files,
the current surveillance standard. The data will be shared with CDC on
a quarterly or yearly basis using a standardized Excel data form, the
ED discharge overdose data form, and standard CDC case definitions. The
total estimated annual burden hours are 1,542. There are no costs to
the respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (hours)
----------------------------------------------------------------------------------------------------------------
State health departments, the DC Rapid ED overdose data 28 12 3
health department and PR health form.
department.
Jurisdictions sharing case-level ED Rapid ED overdose data 24 12 30/60
data with CDC through the NSSP form.
BioSense (OMB #0920-0824).
State health departments, the DC ED discharge overdose 26 4 3
health department and PR health data form.
department.
State health departments, the DC ED discharge overdose 26 1 3
health department and PR health data form--Year.
department.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-14297 Filed 7-3-19; 8:45 am]
BILLING CODE 4163-19-P